Sponsorship

Featured partner placement

Sponsor Virginia Commonwealth University once and your brand appears on the Virginia Commonwealth University page and across every one of its programs and student-startup pages — not just this page.

IncubatorIndirect supportNo equityVerified

Activation Capital / VA Bio+Tech Park

Also known as: VA Bio+Tech Park, Activation Capital, VCU Bio+Tech Park

Virginia Commonwealth University · Richmond, VA

Quick fit check

  • Indirect support only
  • No equity required
  • Currently active
  • Verified by research

Key numbers

Funding range

$0 – $0

Equity

None

Application

Rolling

Regional

Last activity

2026-06-24

High confidence

Known startups and winners

Competition winners and notable student ventures from our research.

See every startup

Activation Capital is an innovation ecosystem development organization that operates the 34-acre VA Bio+Tech Park in downtown Richmond, adjacent to the VCU Medical Center. Founded in 1992 and opened in 1995, the park houses approximately 70 companies, research institutes, and state/federal laboratories in nine buildings totaling roughly 1.5 million square feet. Major tenants include the Altria Center for Research & Technology ($350M facility, 450K sq ft, 600 scientists), the United Network for Organ Sharing (UNOS), and the Virginia Division of Consolidated Laboratory Services.

The park's business incubation program has graduated more than 40 client companies, including three publicly traded firms, which have collectively attracted over $400 million in equity, grant, and strategic capital. A 102,000-square-foot Innovation Center is under development featuring approximately 45,000 square feet of incubator space with shared labs, private offices, and community gathering spaces.

Activation Capital also operates programs including Early Entrepreneurship Guidance, Pre-Accelerator, Accelerator, and Executive+Founder Matchmaking (Pioneer Connect) for life sciences and healthcare startups. It received $15 million from the Commonwealth of Virginia and $52.9 million in federal Build Back Better Regional Challenge funding for an advanced pharmaceutical manufacturing cluster.